Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Bromley, Seddon Thomas, A. Luster (2005)
Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphaticsNature Immunology, 6
T. Shimaoka, N. Kume, M. Minami, K. Hayashida, H. Kataoka, T. Kita, S. Yonehara (2000)
Molecular Cloning of a Novel Scavenger Receptor for Oxidized Low Density Lipoprotein, SR-PSOX, on Macrophages*The Journal of Biological Chemistry, 275
W. Kuziel, Tracey Dawson, Marlon Quinones, Edgar Garavito, G. Chenaux, S. Ahuja, R. Reddick, N. Maeda (2003)
CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice.Atherosclerosis, 167 1
Christoph Seibert, T. Sakmar (2004)
Small-molecule antagonists of CCR5 and CXCR4: a promising new class of anti-HIV-1 drugs.Current pharmaceutical design, 10 17
Yuqing Huo, C. Weber, S. Forlow, M. Sperandio, J. Thatte, M. Mack, Steffen Jung, D. Littman, K. Ley (2001)
The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium.The Journal of clinical investigation, 108 9
D. Mahad, M. Callahan, K. Williams, E. Ubogu, P. Kivisäkk, B. Tucky, G. Kidd, Gillian Kingsbury, Gillian Kingsbury, Ansi Chang, R. Fox, M. Mack, M. Sniderman, R. Ravid, S. Staugaitis, M. Stins, R. Ransohoff (2006)
Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis.Brain : a journal of neurology, 129 Pt 1
G. Debes, C. Arnold, A. Young, S. Krautwald, M. Lipp, J. Hay, E. Butcher (2005)
Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissuesNature Immunology, 6
C. Tsou, C. Haskell, Israel Charo (2001)
Tumor Necrosis Factor- (cid:1) -converting Enzyme Mediates the Inducible Cleavage of Fractalkine*
J. Flier, D. Boorsma, P. Beek, C. Nieboer, T. Stoof, R. Willemze, C. Tensen (2001)
Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammationThe Journal of Pathology, 194
Tracy Handel, P. Domaille (1996)
Heteronuclear (1H, 13C, 15N) NMR assignments and solution structure of the monocyte chemoattractant protein-1 (MCP-1) dimer.Biochemistry, 35 21
I. Charo, W. Peters (2003)
Chemokine Receptor 2 (CCR2) in Atherosclerosis, Infectious Diseases, and Regulation of T‐Cell PolarizationMicrocirculation, 10
A. Bikfalvi (2004)
Platelet factor 4: an inhibitor of angiogenesis.Seminars in thrombosis and hemostasis, 30 3
Yang Pan, C. Lloyd, Hong Zhou, S. Dolich, J. Deeds, J. Gonzalo, J. Vath, M. Gosselin, Jingya Ma, B. Dussault, E. Woolf, G. Alperin, J. Culpepper, J. Gutiérrez-Ramos, D. Gearing (1997)
Neurotactin, a membrane-anchored chemokine upregulated in brain inflammationNature, 387
A. Chaudhuri, P. Behan (2003)
Natalizumab for relapsing multiple sclerosis.The New England journal of medicine, 348 16
K. Garton, P. Gough, C. Blobel, G. Murphy, D. Greaves, P. Dempsey, E. Raines (2001)
Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1).The Journal of biological chemistry, 276 41
S. Weisberg, Deborah Hunter, R. Huber, Jacob Lemieux, S. Slaymaker, K. Vaddi, I. Charo, R. Leibel, A. Ferrante (2006)
CCR2 modulates inflammatory and metabolic effects of high-fat feeding.The Journal of clinical investigation, 116 1
P. Romagnani, L. Lasagni, F. Annunziato, M. Serio, S. Romagnani (2004)
CXC chemokines: the regulatory link between inflammation and angiogenesis.Trends in immunology, 25 4
A. Faggiotto, R. Ross, L. Harker (1984)
Studies of Hypercholesterolemia in the Nonhuman Primate: I. Changes that Lead to Fatty Streak FormationArteriosclerosis, Thrombosis, and Vascular Biology, 4
D. Wuttge, Xinghua Zhou, Y. Sheikine, D. Wågsäter, V. Stemme, U. Hedin, S. Stemme, G. Hansson, A. Sirsjö (2004)
CXCL16/SR-PSOX Is an Interferon-&ggr;–Regulated Chemokine and Scavenger Receptor Expressed in Atherosclerotic LesionsArteriosclerosis, Thrombosis, and Vascular Biology: Journal of the American Heart Association, 24
C. Gerard, B. Rollins (2001)
Chemokines and diseaseNature Immunology, 2
G. Kelner, Jacqueline Kennedy, K. Bacon, S. Kleyensteuber, D. Largaespada, N. Jenkins, N. Copeland, J. Bazan, K. Moore, T. Schall, A. Zlotnik (1994)
Lymphotactin: a cytokine that represents a new class of chemokine.Science, 266 5189
N. Nelken, S. Coughlin, D. Gordon, J. Wilcox (1991)
Monocyte chemoattractant protein-1 in human atheromatous plaques.The Journal of clinical investigation, 88 4
L. Boring, J. Gosling, Michael Cleary, I. Charo (1998)
Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosisNature, 394
Qing Ma, Daniel Jones, P. Borghesani, R. Segal, T. Nagasawa, T. Kishimoto, R. Bronson, T. Springer (1998)
Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice.Proceedings of the National Academy of Sciences of the United States of America, 95 16
M. Feldmann, F. Brennan, E. Paleolog, A. Cope, P. Taylor, Richard Williams, J. Woody, R. Maini (2004)
Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease?Novartis Foundation symposium, 256
D. Mahad, R. Ransohoff (2003)
The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE).Seminars in immunology, 15 1
P. Murphy, M. Baggiolini, I. Charo, C. Hébert, R. Horuk, K. Matsushima, L. Miller, J. Oppenheim, C. Power (2000)
International union of pharmacology. XXII. Nomenclature for chemokine receptors.Pharmacological reviews, 52 1
T. Calzascia, F. Masson, W. Berardino-Besson, E. Contassot, R. Wilmotte, M. Aurrand-Lions, C. Rüegg, P. Dietrich, P. Walker (2005)
Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs.Immunity, 22 2
J. Cyster (2005)
Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs.Annual review of immunology, 23
C. Trebst, T. Sørensen, P. Kivisäkk, M. Cathcart, J. Hesselgesser, R. Horuk, F. Sellebjerg, H. Lassmann, R. Ransohoff (2001)
CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis.The American journal of pathology, 159 5
X. Yu, S. Dluz, D. Graves, L. Zhang, H. Antoniades, W. Hollander, S. Prusty, A. Valente, C. Schwartz, G. Sonenshein (1992)
Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates.Proceedings of the National Academy of Sciences of the United States of America, 89 15
R. Strieter, J. Belperio, R. Phillips, M. Keane (2004)
CXC chemokines in angiogenesis of cancer.Seminars in cancer biology, 14 3
C. Trebst, R. Ransohoff (2001)
Investigating chemokines and chemokine receptors in patients with multiple sclerosis: opportunities and challenges.Archives of neurology, 58 12
C. Gerhardt, I. Romero, R. Cancello, L. Camoin, A. Strosberg (2001)
Chemokines control fat accumulation and leptin secretion by cultured human adipocytesMolecular and Cellular Endocrinology, 175
A. Mantovani (1999)
The chemokine system: redundancy for robust outputs.Immunology today, 20 6
A. Proudfoot, T. Handel, Z. Johnson, E. Lau, P. LiWang, I. Clark‐Lewis, F. Borlat, T. Wells, M. Kosco-Vilbois (2003)
Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokinesProceedings of the National Academy of Sciences of the United States of America, 100
Pia Kivisäkk, Corinna Trebst, Zhugong Liu, B. Tucky, T. Sørensen, R. Rudick, Matthias Mack, R. Ransohoff (2002)
T‐cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS traffickingClinical & Experimental Immunology, 129
R. Devalaraja, L. Nanney, Qinghua Qian, Jianguo Du, Yingchun Yu, M. Devalaraja, A. Richmond (2000)
Delayed wound healing in CXCR2 knockout mice.The Journal of investigative dermatology, 115 2
J. Gosling, S. Slaymaker, L. Gu, S. Tseng, Constance Zlot, Stephen Young, B. Rollins, I. Charo (1999)
MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B.The Journal of clinical investigation, 103 6
K. Uysal, S. Wiesbrock, M. Marino, G. Hotamisligil (1997)
Protection from obesity-induced insulin resistance in mice lacking TNF-α functionNature, 389
R. Gerszten, E. García-Zepeda, Y. Lim, M. Yoshida, Han Ding, M. Gimbrone, A. Luster, F. Luscinskas, A. Rosenzweig (1999)
MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditionsNature, 398
Richard Horuk (1999)
Chemokine receptors and HIV-1: the fusion of two major research fields.Immunology today, 20 2
B. Kahn, J. Flier (2000)
Obesity and insulin resistance.The Journal of clinical investigation, 106 4
G. Müller, U. Höpken, M. Lipp (2003)
The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunityImmunological Reviews, 195
D. Campbell, Chang Kim, E. Butcher (2003)
Chemokines in the systemic organization of immunityImmunological Reviews, 195
P. Lesnik, C. Haskell, I. Charo (2003)
Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis.The Journal of clinical investigation, 111 3
M. Matloubian, A. David, Sharon Engel, J. Ryan, J. Cyster (2000)
A transmembrane CXC chemokine is a ligand for HIV-coreceptor BonzoNature Immunology, 1
E. Lew, E. Stoffel (2003)
Natalizumab for active Crohn's disease.The New England journal of medicine, 348 16
J. Cyster, V. Ngo, E. Ekland, Michael Gunn, J. Sedgwick, K. Ansel (1999)
Chemokines and B-cell homing to follicles.Current topics in microbiology and immunology, 246
A. Valdes, M. Wolfe, E. O’Brien, N. Spurr, W. Gefter, A. Rut, P. Groot, D. Rader (2002)
Val64Ile Polymorphism in the C-C Chemokine Receptor 2 Is Associated With Reduced Coronary Artery CalcificationArteriosclerosis, Thrombosis, and Vascular Biology: Journal of the American Heart Association, 22
A. Fong, L. Robinson, D. Steeber, T. Tedder, O. Yoshie, T. Imai, D. Patel (1998)
Fractalkine and CX3CR1 Mediate a Novel Mechanism of Leukocyte Capture, Firm Adhesion, and Activation under Physiologic FlowThe Journal of Experimental Medicine, 188
L. Gu, Y. Okada, S. Clinton, C. Gerard, G. Sukhova, P. Libby, B. Rollins (1998)
Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice.Molecular cell, 2 2
J. Friedman (2002)
The function of leptin in nutrition, weight, and physiology.Nutrition reviews, 60 10 Pt 2
J. Cyster (2003)
Lymphoid organ development and cell migrationImmunological Reviews, 195
I. Charo (1999)
CCR2: from cloning to the creation of knockout mice.Chemical immunology, 72
S. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R. Leibel, A. Ferrante (2003)
Obesity is associated with macrophage accumulation in adipose tissue.The Journal of clinical investigation, 112 12
James Campbell, James Campbell, E. Butcher (2000)
Chemokines in tissue-specific and microenvironment-specific lymphocyte homing.Current opinion in immunology, 12 3
Kazunobu Tachibana, S. Hirota, H. Iizasa, H. Yoshida, K. Kawabata, Y. Kataoka, Y. Kitamura, K. Matsushima, N. Yoshida, S. Nishikawa, T. Kishimoto, T. Nagasawa (1998)
The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tractNature, 393
B. Rovin, Ling Lu, R. Saxena (1999)
A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression.Biochemical and biophysical research communications, 259 2
K. Bacon, M. Baggiolini, H. Broxmeyer, R. Horuk, I. Lindley, A. Mantovani, K. Maysushima, P. Murphy, H. Nomiyama, J. Oppenheim, A. Rot, T. Schall, M. Tsang, R. Thorpe, J. Damme, M. Wadhwa, O. Yoshie, A. Zlotnik, K. Zoon (2002)
Chemokine/chemokine receptor nomenclature.Journal of immunological methods, 262 1-2
C. Combadière, Stephane Potteaux, Ji-Liang Gao, B. Esposito, S. Casanova, Eric Lee, P. Debré, A. Tedgui, P. Murphy, Z. Mallat (2003)
Decreased Atherosclerotic Lesion Formation in CX3CR1/Apolipoprotein E Double Knockout MiceCirculation: Journal of the American Heart Association, 107
Y. Zou, A. Kottmann, M. Kuroda, I. Taniuchi, D. Littman (1998)
Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar developmentNature, 393
S. Sozzani, P. Allavena, A. Vecchi, A. Mantovani (2000)
Chemokines and Dendritic Cell TrafficJournal of Clinical Immunology, 20
J. Cyster (1999)
Chemokines and cell migration in secondary lymphoid organs.Science, 286 5447
T. Sørensen, M. Tani, Jakob Jensen, V. Pierce, C. Lucchinetti, V. Folcik, S. Qin, J. Rottman, F. Sellebjerg, R. Strieter, J. Frederiksen, R. Ransohoff (1999)
Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients.The Journal of clinical investigation, 103 6
W. Boisvert, R. Santiago, L. Curtiss, R. Terkeltaub (1998)
A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice.The Journal of clinical investigation, 101 2
L. Gu, S. Tseng, Renée Horner, Carmen Tam, M. Loda, B. Rollins (2000)
Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1Nature, 404
R. Ransohoff, P. Kivisäkk, G. Kidd (2003)
Three or more routes for leukocyte migration into the central nervous systemNature Reviews Immunology, 3
David McDermott, A. Fong, Qiong Yang, Joan Sechler, L. Cupples, Maya Merrell, Peter Wilson, Ralph D'Agostino, Christopher O’Donnell, Dhavalkumar Patel, Philip Murphy (2003)
Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans.The Journal of clinical investigation, 111 8
P. Kivisäkk, D. Mahad, M. Callahan, C. Trebst, B. Tucky, T. Wei, Lijun Wu, Espen Baekkevold, H. Lassmann, S. Staugaitis, J. Campbell, R. Ransohoff (2003)
Human cerebrospinal fluid central memory CD4+ T cells: Evidence for trafficking through choroid plexus and meninges via P-selectinProceedings of the National Academy of Sciences of the United States of America, 100
D. Mahad, C. Trebst, P. Kivisäkk, S. Staugaitis, B. Tucky, T. Wei, C. Lucchinetti, H. Lassmann, R. Ransohoff (2004)
Expression of Chemokine Receptors CCR1 and CCR5 Reflects Differential Activation of Mononuclear Phagocytes in Pattern II and Pattern III Multiple Sclerosis LesionsJNEN: Journal of Neuropathology & Experimental Neurology, 63
Haiyan Xu, Glenn Barnes, Qing Yang, G. Tan, Daseng Yang, C. Chou, Jason Sole, A. Nichols, J. Ross, L. Tartaglia, Hong Chen (2003)
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.The Journal of clinical investigation, 112 12
Bazan Jf, K. Bacon, G. Hardiman, Wei Wang, K. Soo, D. Rossi, D. Greaves, A. Zlotnik, T. Schall (1997)
A new class of membrane-bound chemokine with a CX3C motifNature, 385
L. Gu, S. Tseng, B. Rollins (1999)
Monocyte chemoattractant protein-1.Chemical immunology, 72
A. Rot, U. Andrian (2004)
Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells.Annual review of immunology, 22
P. González, R. Álvarez, A. Batalla, J. Reguero, V. Álvarez, A. Astudillo, G. Cubero, A. Cortina, E. Coto (2001)
Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarctionGenes and Immunity, 2
C. Szalai, J. Duba, Z. Prohászka, Á. Kalina, T. Szabó, B. Nagy, L. Horváth, A. Császár (2001)
Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients.Atherosclerosis, 158 1
M. Martins-Green, H. Hanafusa (1997)
The 9E3/CEF4 gene and its product the chicken chemotactic and angiogenic factor (cCAF): potential roles in wound healing and tumor development.Cytokine & growth factor reviews, 8 3
K. Reif, E. Ekland, L. Ohl, H. Nakano, M. Lipp, R. Förster, J. Cyster (2002)
Balanced responsiveness to chemoattractants from adjacent zones determines B-cell positionNature, 416
A. Pradhan, J. Manson, N. Rifai, Julie Buring, P. Ridker (2001)
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.JAMA, 286 3
A. Luster (1998)
Chemokines--chemotactic cytokines that mediate inflammation.The New England journal of medicine, 338 7
C. Haskell, Michael Cleary, I. Charo (1999)
Molecular Uncoupling of Fractalkine-mediated Cell Adhesion and Signal TransductionThe Journal of Biological Chemistry, 274
R. Black (2002)
Tumor necrosis factor-alpha converting enzyme.The international journal of biochemistry & cell biology, 34 1
P. Kivisäkk, D. Mahad, M. Callahan, K. Sikora, C. Trebst, B. Tucky, J. Wujek, R. Ravid, S. Staugaitis, H. Lassmann, R. Ransohoff (2004)
Expression of CCR7 in multiple sclerosis: Implications for CNS immunityAnnals of Neurology, 55
C. Daly, B. Rollins (2003)
Monocyte Chemoattractant Protein‐1 (CCL2) in Inflammatory Disease and Adaptive Immunity: Therapeutic Opportunities and ControversiesMicrocirculation, 10
M. Baggiolini (2001)
Chemokines in pathology and medicineJournal of Internal Medicine, 250
In this review, the authors discuss the properties of chemokines and their receptors and highlight the roles of these chemoattractants in selected clinical disorders.
The New England Journal of Medicine – The New England Journal of Medicine
Published: Feb 9, 2006
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.